SCHEMBL30639067

SCHEMBL30639067

N#Cc1ccc2c(c1)C(=O)c1nc3c(Nc4ccc(F)cc4)cccc3c(=O)n1-2

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 15/20 0.47
▸ TDO2 P48775 13/20 0.47
▸ IDO2 Q6ZQW0 10/20 0.47
▸ APAF1 O14727 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CDC7 O00311 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26614101 1.00 IDO1 (0.47) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26614249 0.89 IDO1 (0.60) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26857749 0.88 TDP2 (0.36) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26864086 0.88 TDP2 (0.36) IDO1TDO2IDO2APAF1MEN1
SCHEMBL30639114 0.86 IDO1 (0.42) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26614215 0.86 IDO1 (0.42) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26614138 0.85 IDO1 (0.55) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26857752 0.82 IDO1 (0.44) IDO1TDO2IDO2APAF1MEN1
SCHEMBL26855808 0.82 IDO1 (0.48) IDO1TDO2IDO2APAF1MEN1
Hydrochloric Acid SCHEMBL30639053 0.81 IDO1 (0.43) IDO1TDO2IDO2APAF1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514804-A1 TRYPTANTHRIN DERIVATIVES AND USES THEREOF Viscient Bio, Inc. (US) 2025-03-05 — — EP disclosed
CN-119487031-A Tryptanthrin derivatives and uses thereof 威森特生物公司 2025-02-18 — — CN disclosed
WO-2023211977-A1 TRYPTANTHRIN DERIVATIVES AND USES THEREOF VISCIENT BIO, INC. (US) 2023-11-02 — — WO disclosed
Send feedback